China National Pharmaceutical Group Co Ltd (Sinopharm) has a healthcare industrial platform with Sinopharm Healthcare Corporation as its core. 

Sinopharm has eight tertiary hospitals, 21 secondary and specialized hospitals and 141 medical institutions nationwide, as well as more than 20,000 medical workers and over 20,000 beds.

These resources have formed a multi-dimensional pattern of joint development between comprehensive hospitals and specialized medical institutions in areas such as stomatology, maternal and child healthcare, medical aesthetics and blood purification, generating annual revenue of nearly 10 billion yuan ($1.38 billion).